Evidence map›Paper›PMID 1733625›Full record

ReviewClinical and experimental immunology1992

Molecular heterogeneity of human IgA antibodies during an immune response.

M W Russell, C Lue, A W van den Wall Bake, Z Moldoveanu, J Mestecky

Abstract readReview
In one paragraph

Review in Clinical and experimental immunology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Structural promiscuity in the human circulatory IgA1 clonal repertoire.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Methods for evaluation of humoral immune responses in human genital tract secretions.American journal of reproductive immunology (New York, N.Y. : 1989) · 2011
    Review
  10. Stone age diseases and modern AIDS.Virology journal · 2008
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Pathogenesis of idiopathic IgA nephropathy.Pediatric nephrology (Berlin, Germany) · 1993
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M W RussellDepartment of Microbiology, University of Alabama, Birmingham 35294.
C Lue
A W van den Wall Bake
Z Moldoveanu
J Mestecky

Funding

ROLE OF IGA B-CELLS IN DISEASEP01AI018745 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MESTECKY, JIRI F · 1985 to 1991
–
SECRETORY IGA SYSTEM: MOLECULAR-CELLULAR INTERACTIONSR01AI010854 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MESTECKY, JIRI F · 1985 to 1990
–
RECEPTOR-MEDIATED BINDING OF IGA TO HEPATOCYTESR01DK028537 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MESTECKY, JIRI F · 1986 to 1995
–
NIAID NIH HHS AI-10854NIAID NIH HHS AI-18745NIDDK NIH HHS DK-28537
6 · The paper itself

Abstract

Human IgA occurs in multiple molecular forms (polymeric and monomeric) and two subclasses which show differential distribution between the mucosal and circulatory compartments of the immune system. However, the molecular form and subclass of specific IgA antibodies are influenced, especially during an immune response, by the type of antigen and duration of the response as well as by the route of exposure. These considerations question previously held notions that polymeric IgA and an increased representation of the IgA2 subclass among circulating antibodies or antibody-secreting cells signify their mucosal origin. Although the functional properties of different molecular forms and subclasses of IgA antibodies are incompletely understood, it appears that there is physiological benefit in the diversity of the IgA immune system.

Indexed as

AnimalsAntibody FormationHumansImmunoglobulin AImmunoglobulin A

Identifiers

PMID1733625
PMCPMC1554245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.